200 related articles for article (PubMed ID: 26708616)
1. Apoptosis in human myelodysplastic syndrome CD34+ cells is modulated by the upregulation of TLRs and histone H4 acetylation via a β-arrestin 1 dependent mechanism.
Zeng Q; Shu J; Hu Q; Zhou SH; Qian YM; Hu MH; Hu LY; Wang YG; Zhou YM; Lu JH
Exp Cell Res; 2016 Jan; 340(1):22-31. PubMed ID: 26708616
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor alterations in myelodysplastic syndrome.
Wei Y; Dimicoli S; Bueso-Ramos C; Chen R; Yang H; Neuberg D; Pierce S; Jia Y; Zheng H; Wang H; Wang X; Nguyen M; Wang SA; Ebert B; Bejar R; Levine R; Abdel-Wahab O; Kleppe M; Ganan-Gomez I; Kantarjian H; Garcia-Manero G
Leukemia; 2013 Sep; 27(9):1832-40. PubMed ID: 23765228
[TBL] [Abstract][Full Text] [Related]
3. β-arrestin-1 is a nuclear transcriptional regulator of endothelin-1-induced β-catenin signaling.
Rosanò L; Cianfrocca R; Tocci P; Spinella F; Di Castro V; Spadaro F; Salvati E; Biroccio AM; Natali PG; Bagnato A
Oncogene; 2013 Oct; 32(42):5066-77. PubMed ID: 23208497
[TBL] [Abstract][Full Text] [Related]
4. Effects of arsenic disulfide on apoptosis, histone acetylation, toll like receptor 2 activation, and erythropoiesis in bone marrow mononuclear cells of myelodysplastic syndromes patients in vitro.
Xu M; Ren JY; Guo YC; Xu BX; Zeng Q; Hu Q; Zhou YM; Lu JH
Leuk Res; 2017 Nov; 62():4-11. PubMed ID: 28963909
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor-4 is up-regulated in hematopoietic progenitor cells and contributes to increased apoptosis in myelodysplastic syndromes.
Maratheftis CI; Andreakos E; Moutsopoulos HM; Voulgarelis M
Clin Cancer Res; 2007 Feb; 13(4):1154-60. PubMed ID: 17317824
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis in relation to CD34 antigen expression in normal and myelodysplastic bone marrow.
Pecci A; Travaglino E; Klersy C; Invernizzi R
Acta Haematol; 2003; 109(1):29-34. PubMed ID: 12486320
[TBL] [Abstract][Full Text] [Related]
7. A nuclear function of beta-arrestin1 in GPCR signaling: regulation of histone acetylation and gene transcription.
Kang J; Shi Y; Xiang B; Qu B; Su W; Zhu M; Zhang M; Bao G; Wang F; Zhang X; Yang R; Fan F; Chen X; Pei G; Ma L
Cell; 2005 Dec; 123(5):833-47. PubMed ID: 16325578
[TBL] [Abstract][Full Text] [Related]
8. GATA-1 transcription factor is up-regulated in bone marrow hematopoietic progenitor CD34(+) and erythroid CD71(+) cells in myelodysplastic syndromes.
Maratheftis CI; Bolaraki PE; Voulgarelis M
Am J Hematol; 2007 Oct; 82(10):887-92. PubMed ID: 17570514
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of miR-125a in myelodysplastic syndrome CD34+ cells modulates NF-κB activation and enhances erythroid differentiation arrest.
Gañán-Gómez I; Wei Y; Yang H; Pierce S; Bueso-Ramos C; Calin G; Boyano-Adánez Mdel C; García-Manero G
PLoS One; 2014; 9(4):e93404. PubMed ID: 24690917
[TBL] [Abstract][Full Text] [Related]
10. CD34+ cells from patients with myelodysplastic syndrome present different p21 dependent premature senescence.
Xiao Y; Wang J; Song H; Zou P; Zhou D; Liu L
Leuk Res; 2013 Mar; 37(3):333-40. PubMed ID: 23219618
[TBL] [Abstract][Full Text] [Related]
11. Significance of CD34(-) and CD34(+) cell apoptosis and proliferation in bone marrow of patients with MDS and their impact on survival.
Xia B; Guo Q; Zhao DD; Zhao HF; Han XP; Wang H; Wu XX; Zhang YZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1392-7. PubMed ID: 23257440
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptor and cytokine expression throughout the bone marrow differs between patients with low- and high-risk myelodysplastic syndromes.
Paracatu LC; Monlish DA; Greenberg ZJ; Fisher DAC; Walter MJ; Oh ST; Schuettpelz LG
Exp Hematol; 2022 Jun; 110():47-59. PubMed ID: 35367529
[TBL] [Abstract][Full Text] [Related]
13. Beta-arrestin1 and 2 differently modulate metabotropic glutamate receptor 7 signaling in rat developmental sevoflurane-induced neuronal apoptosis.
Wang WY; Wu XM; Jia LJ; Zhang HH; Cai F; Mao H; Xu WC; Chen L; Zhang J; Hu SF
Neuroscience; 2016 Jan; 313():199-212. PubMed ID: 26621121
[TBL] [Abstract][Full Text] [Related]
14. Global H3K4me3 genome mapping reveals alterations of innate immunity signaling and overexpression of JMJD3 in human myelodysplastic syndrome CD34+ cells.
Wei Y; Chen R; Dimicoli S; Bueso-Ramos C; Neuberg D; Pierce S; Wang H; Yang H; Jia Y; Zheng H; Fang Z; Nguyen M; Ganan-Gomez I; Ebert B; Levine R; Kantarjian H; Garcia-Manero G
Leukemia; 2013 Nov; 27(11):2177-86. PubMed ID: 23538751
[TBL] [Abstract][Full Text] [Related]
15. [STAT5 phosphorylation in CD34(+)CD38(-)CD123(+) bone marrow cells of the patients with myelodysplastic syndrome].
Liu BN; Fu R; Wang HQ; Li LJ; Yue LZ; Ruan EB; Qu W; Liang Y; Wang GJ; Wang XM; Liu H; Wu YH; Song J; Xing LM; Guan J; Wang J; Shao ZH
Zhonghua Xue Ye Xue Za Zhi; 2012 Jun; 33(6):480-3. PubMed ID: 22967386
[TBL] [Abstract][Full Text] [Related]
16. [Differentiation and expression of membrane hemopoietic cytokine receptors on CD34+ bone marrow cells in patients with myelodysplastic syndromes].
Li LJ; Fu R; Wang HQ; Yue LZ; Liu H; Wang J; Wang HL; Ruan EB; Qu W; Liang Y; Wang GJ; Wang XM; Liu H; Song J; Wu YH; Xing LM; Guan J; Shao ZH
Zhonghua Yi Xue Za Zhi; 2011 Jan; 91(4):234-8. PubMed ID: 21418866
[TBL] [Abstract][Full Text] [Related]
17. Expression of FLIP(Long) and FLIP(Short) in bone marrow mononuclear and CD34+ cells in patients with myelodysplastic syndrome: correlation with apoptosis.
Benesch M; Platzbecker U; Ward J; Deeg HJ; Leisenring W
Leukemia; 2003 Dec; 17(12):2460-6. PubMed ID: 14562111
[TBL] [Abstract][Full Text] [Related]
18. Non-Hematopoietic β-Arrestin1 Confers Protection Against Experimental Colitis.
Lee T; Lee E; Arrollo D; Lucas PC; Parameswaran N
J Cell Physiol; 2016 May; 231(5):992-1000. PubMed ID: 26479868
[TBL] [Abstract][Full Text] [Related]
19. Expressions of CD96 and CD123 in Bone Marrow Cells of Patients with Myelodysplastic Syndromes.
Zhang W; Shao Z; Fu R; Wang H; Li L; Liu H
Clin Lab; 2015; 61(10):1429-34. PubMed ID: 26642704
[TBL] [Abstract][Full Text] [Related]
20. CD34+ cells from acute myeloid leukemia, myelodysplastic syndromes, and normal bone marrow display different apoptosis and drug resistance-associated phenotypes.
Suárez L; Vidriales MB; García-Laraña J; Sanz G; Moreno MJ; López A; Barrena S; Martínez R; Tormo M; Palomera L; Lavilla E; López-Berges MC; de Santiago M; de Equiza ME; Miguel JF; Orfao A
Clin Cancer Res; 2004 Nov; 10(22):7599-606. PubMed ID: 15569991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
